Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taiwan Says 23 Million Using $3.68 Billion In Covered Drugs

This article was originally published in PharmAsia News

Executive Summary

Taiwan counts 23 million of its people consuming nearly $3.68 billion worth of drugs a year, and that does not include drugs not covered by national insurance. The nation's Bureau of National health Insurance said the consumption also continues to increase, with cardiovascular-disease drugs rising the fastest. Among them are amiodipine, losartan and valserian, all for lowering blood pressure and costing the government $572 million. Atorvastatin and other drugs for lowering cholesterol cost the national health-insurance plan $165 million. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel